TCL Archive Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer June 24, 2005
TCL Archive Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends. August 6, 2004
